Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Open Access
- 21 July 1999
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 282 (3) , 267-270
- https://doi.org/10.1001/jama.282.3.267
Abstract
In traditional hospital practice most of the burden of drug therapy decision making falls on the physician. However, studies have shown that physicians sometimes make errors in prescribing drugs.1,2 While most errors are harmless or are intercepted, some result in adverse drug events (ADEs). The pharmacist's role in prescribing is typically reactive: responding to prescription errors long after the decision has been made for patients about whom he or she has little direct clinical knowledge. Thus, the specialized knowledge of the pharmacist is not utilized when it would be most useful: at the time of ordering.Keywords
This publication has 5 references indexed in Scilit:
- Effect of Computerized Physician Order Entry and a Team Intervention on Prevention of Serious Medication ErrorsJAMA, 1998
- A Computer-Assisted Management Program for Antibiotics and Other Antiinfective AgentsNew England Journal of Medicine, 1998
- Impact of a clinical pharmacist in a multidisciplinary intensive care unitCritical Care Medicine, 1994
- Incidence and preventability of adverse drug events in hospitalized adultsJournal of General Internal Medicine, 1993
- Incidence of Adverse Events and Negligence in Hospitalized PatientsNew England Journal of Medicine, 1991